Trial Profile
Long-term, efficacy and safety of alfuzosin 10 mg od on the risk of acute urinary retention and the need for surgery in patients with BPH [benign prostatic hyperplasia]
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Sep 2006
Price :
$35
*
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Sanofi-Synthelabo
- 13 Sep 2006 New trial record.